Old Wine in New Pipes? Treatment of Advanced Non-Small Cell Lung Cancer with Trofosfamide

Publisher： Karger

E-ISSN： 2296-5262|36|7-8|409-413

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.36, Iss.7-8, 2013-07, pp. : 409-413

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Pilot Study of Docetaxel and Trofosfamide as Second-Line ‘Metronomic’ Chemotherapy in the Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC)

By  

Oncology Research and Treatment, Vol. 31, Iss. 4, 2008-03 ,pp. : 185-189

Karger

Access to resources Recommend Favorite

Interaction of Treatment and Biomarker in Advanced Non-small Cell Lung Cancer

By  

Reviews on Recent Clinical Trials, Vol. 12, Iss. 1, 2017-01 ,pp. : 51-58

Bentham Science Publishers

Access to resources Recommend Favorite

New Agents in Advanced Non-Small-Cell Lung Cancer Treatment

By  

Oncology, Vol. 77, Iss. 1, 2010-02 ,pp. : 103-112

Karger

Access to resources Recommend Favorite

Chemotherapy in Elderly Patients with Advanced Lung Cancer Part II: Treatment of Non-Small Cell Lung Cancer (NSCLC)

By  

Oncology Research and Treatment, Vol. 27, Iss. 6, 2004-12 ,pp. : 583-588

Karger

Access to resources Recommend Favorite

Bevacizumab in the Treatment of Advanced, Non-Squamous Non-Small Cell Lung Cancer: An Evidence-Based Approach

By  

Oncology, Vol. 80, Iss. 5-6, 2011-07 ,pp. : 350-358

Karger

Access to resources Recommend Favorite